Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor-induced signal transduction by cleavage of the T-cell protein tyrosine phosphatase

Hepatology

Volumn 49, Issue 6, 2009, Pages 1810-1820

  Brenndörfer, Erwin Daniel ^a   Karthe, Julianne ^a   Frelin, Lars ^b   Cebula, Patricia ^a   Erhardt, Andreas ^a   am Esch, Jan Schulte ^a   Hengel, Hartmat ^c   Bartenschlager, Ralf ^d   Sällberg, Matti ^b   Häussinger, Dieter ^a   Bode, Johannes Georg ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4A; POLYPROTEIN; PROTEIN KINASE B; VIRUS PROTEIN;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; BINDING SITE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER DEVELOPMENT; LIVER REGENERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ADULT; AGED; EPIDERMAL GROWTH FACTOR; FEMALE; HEPACIVIRUS; HUMANS; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 2; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; VIRAL NONSTRUCTURAL PROTEINS;

EID: 68949105585     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22857     Document Type: Article

References (27)

1. Moradpour D, Penin F, Rice CM. Replication of hepatitis C virus. Nat Rev Microbiol 2007;5:453-463.
2. Bode JG, Brenndorfer ED, Haussinger D. Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response. Biol Chem 2008;389:1283-1298.
3. Frelin L, Brenndorfer ED, Ahlen G, Weiland M, Hultgren C, Alheim M, et al. The hepatitis C virus and immune evasion: Non-structural 3/4A transgenic mice are resistant to lethal tumour necrosis factor {alpha} mediated liver disease. Gut 2006;55:1475-1483.
4. Moriishi K, Matsuura Y. Host factors involved in the replication of hepatitis C virus. Rev Med Virol 2007;17:343-354.
5. He Y, Nakao H, Tan SL, Polyak SJ, Neddermann P, Vijaysri S, et al. Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase. J Virol 2002;76:9207-9217.
6. Ishida H, Li K, Yi M, Lemon SM. p21-activated kinase 1 is activated through the mammalian target of rapamycin/p70 S6 kinase pathway and regulates the replication of hepatitis C virus in human hepatoma cells. J Biol Chem 2007;282:11836-11848.
7. Mannova P, Beretta L. Activation of the N-Ras-PI3K-Akt-mTOR pathway by hepatitis C virus: Control of cell survival and viral replication. J Virol 2005;79:8742-8749.
8. Waris G, Siddiqui A. Hepatitis C virus stimulates the expression of cyclooxygenase-2 via oxidative stress: Role of prostaglandin E2 in RNA replication. J Virol 2005;79:9725-9734.
9. Carver RS, Stevenson MC, Scheving LA, Russell WE. Diverse expression of ErbB receptor proteins during rat liver development and regeneration. Gastroenterology 2002;123:2017-2027.
10. Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999;285:110-113.
11. Sambrook J, Russel D. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2000.
12. Ehlting C, Lai WS, Schaper F, Brenndorfer ED, Matthes RJ, Heinrich PC, et al. Regulation of suppressor of cytokine signaling 3 (SOCS3) mRNA stability by TNF-{alpha} involves activation of the MKK6/p38MAPK/MK2 cascade. J Immunol 2007;178:2813-2826.
13. Denk A, Goebeler M, Schmid S, Berberich I, Ritz O, Lindemann D, et al. Activation of NF-kappa B via the Ikappa B kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells. J Biol Chem 2001;276:28451-28458.
14. Agazie YM, Hayman MJ. Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling. Mol Cell Biol 2003;23:7875-7886.
15. Haj FG, Verveer PJ, Squire A, Neel BG, Bastiaens PI. Imaging sites of receptor dephosphorylation by PTP1B on the surface of the endoplasmic reticulum. Science 2002;295:1708-1711.
16. Tiganis T, Bennett AM, Ravichandran KS, Tonks NK. Epidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T-cell protein tyrosine phosphatase. Mol Cell Biol 1998;18:1622-1634.
17. Mattila E, Pellinen T, Nevo J, Vuoriluoto K, Arjonen A, Ivaska J. Negative regulation of EGFR signalling through integrin-alpha1beta1-mediated activation of protein tyrosine phosphatase TCPTP. Nat Cell Biol 2005;7: 78-85.
18. van Vliet C, Bukczynska PE, Puryer MA, Sadek CM, Shields BJ, Tremblay ML, et al. Selective regulation of tumor necrosis factor-induced Erk signaling by Src family kinases and the T cell protein tyrosine phosphatase. Nat Immunol 2005;6:253-260.
19. Sale EM, Sale GJ. Protein kinase B: Signalling roles and therapeutic targeting. Cell Mol Life Sci 2008;65:113-127.
20. Sato S, Fujita N, Tsuruo T. Modulation of Akt kinase activity by binding to Hsp90. Proc Natl Acad Sci U S A 2000;97:10832-10837.
21. Chen J, Martin BL, Brautigan DL. Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. Science 1992;257: 1261-1264.
22. Yang L, Dan HC, Sun M, Liu Q, Sun XM, Feldman RI, et al. Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt. Cancer Res 2004;64:4394-4399.
23. Scheuer PJ, Krawczynski K, Dhillon AP. Histopathology and detection of hepatitis C virus in liver. Springer Semin Immunopathol 1997;19:27-45.
24. Loo YM, Owen DM, Li K, Erickson AK, Johnson CL, Fish PM, et al. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci U S A 2006;103:6001-6006.
25. Agnello V, Abel G, Knight GB, Muchmore E. Detection of widespread hepatocyte infection in chronic hepatitis C. HEPATOLOGY 1998;28:573-584.
26. Street A, Macdonald A, Crowder K, Harris M. The hepatitis C virus NS5A protein activates a phosphoinositide 3-kinase-dependent survival signaling cascade. J Biol Chem 2004;279:12232-12241.
27. Alisi A, Giannini C, Spaziani A, Caini P, Zignego AL, Balsano C. Involvement of PI3K in HCV-related lymphoproliferative disorders. J Cell Physiol 2008;214:396-404.